• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

OnCURE Medical Corp. Expands Its California Network By Adding Santa Cruz Radiation Oncology Medical Group

Posted on: Monday, 8 January 2007, 09:01 CST

OnCURE Medical Corp. ("OnCURE"), a leading provider of freestanding radiation therapy services, today announced that it acquired Santa Cruz Radiation Oncology Medical Group, Inc. ("Santa Cruz").

Santa Cruz has owned and operated a radiation center in Santa Cruz, California since 1978.

Dr. Shyam Paryani, Chairman of the OnCURE Board of Directors, stated, "We are excited about this transaction with Santa Cruz and to be associated with Drs. Edmund Sacks, Jay Meisel, and Charlotte Kim, all of whom have excellent practice standards and are affiliated with Stanford Medical School."

Dr. Edmund Sacks, the founding partner of Santa Cruz, added, "We are excited to be associated with OnCURE and its affiliated physician groups throughout California. We look forward to continuing to provide quality care to our patients, while associating with OnCURE for capital and expert support resources."

"OnCURE is the largest freestanding provider of radiation therapy services in the State of California, and with the addition of Santa Cruz to our existing network, it ensures our continued commitment to expand our regional networks of radiation centers in association with quality doctors," said Rick Zehner, Chief Executive Officer of OnCURE.

About OnCURE

OnCURE, headquartered in Newport Beach, California, owns, operates and manages 35 radiation centers, all located in California and Florida. OnCURE's centers provide treatment areas and equipment for radiation therapy and diagnostic radiology, including IMRT, IGRT, CT, and PETCT. OnCURE does not own physician practices nor does it maintain any control over the provision of medical services at its centers. OnCURE does, however, provide capital, technology, and management expertise to its affiliated physician groups, including clinical staff & management, billing and collection, data warehousing, accounting, compliance and other administrative services. OnCURE is associated with a Medical Advisory Board comprised of all of the radiation oncologists whom provide medical services to the OnCURE facilities. Currently there are approximately 58 physicians on the Medical Advisory Board. For more information on OnCURE, please visit our web site at www.OnCURE.com.

OnCURE is a privately held company whose shareholders include Genstar Capital, LLC, Ares Management, LLC, Caisse de Dupot, and OnCURE management.

Forward-Looking Statements

Statements in this Press Release that are not historical facts constitute "forward-looking statements." Any statements contained herein which are not historical facts or which contain the words "anticipate,""believe,""continue,""estimate,""expect,""intend,""may,""should," and similar expressions are intended to identify forward-looking statements. Such statements reflect the current view of OnCURE with respect to future events and are subject to certain risks, uncertainties and assumptions, including, but not limited to, the risk that OnCURE may not be able to implement its growth strategy in the intended manner, including the ability to identify, finance, complete and integrate acquisitions and joint venture opportunities, risks regarding currently unforeseen competitive pressures and risks affecting OnCURE's industry, such as increased regulatory compliance and changes in regulatory requirements, changes in payor reimbursement levels and the development of additional alternative treatment modalities and technological changes. Should one or more of those risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein.

Source: Business Wire

More News in this Category